Contrarian Corpus

188 documents showing 1–60

Muddy Waters 2026-03-30

SoFi Technologies SOFI

SOFI booked a $312M JPMorgan borrowing as a loan sale, inflating ~$1B of EBITDA and enriching management while shareholders absorb ~15% annual dilution.

N4 V3 C2
Muddy Waters 2026-03-22

SoFi Technologies SOFI

SOFI's silence on 11 specific accounting questions confirms Muddy Waters' view that 2025 Adjusted EBITDA is inflated ~90% via mislabeled financings, hidden debt, and misstated risk retention.

N4 V2 C2
Muddy Waters 2026-03-17

SoFi Technologies, Inc. SOFI

SoFi's $1,054M reported 2025 EBITDA is ~90% inflated via manipulated charge-off rates, off-balance-sheet VIEs and subsidized seller-financed sales that feed CEO Noto's comp — real EBITDA is ~$103M.

N5 V3 C3
Kerrisdale Capital 2025-09-01

Pure Storage, Inc. PSTG

Pure Storage's hyperscaler dream is hype: HDDs dominate at 5-6x TCO advantage, the Meta deal is replicable, and Pure deserves a peer multiple, implying ~55% downside to $35.

N4 V3 C3
Kerrisdale Capital 2025-08-01

Aurora Innovation, Inc. AUR

Aurora's autonomous trucking vision is a dead end: tech can only enable hub-and-spoke freight, drayage kills the economics, and the real TAM is smaller than the company's $13bn market cap.

N4 V3 C2
Muddy Waters 2025-05-07

AppLovin Corporation APP

Muddy Waters is short AppLovin; the CEO and CTO's March 2025 denials of persistent identifiers are demonstrably false, exposing APP to deplatforming, regulatory, and margin-compression risks.

N4 V3 C3
Kerrisdale Capital 2025-04-01

D-Wave Quantum Inc QBTS

D-Wave's quantum annealing is a commercial dead end, its 'hybrid' solvers are almost entirely classical, and at 57x 2026E revenue the stock will collapse as reality sets in.

N4 V3 C2
Muddy Waters 2025-03-27

AppLovin APP

AppLovin's e-commerce ad boom is built on fingerprinting that violates Meta/Google/Apple TOS; only 25-35% of sales are incremental and Q1 churn is already 23%.

N4 V3 C2
Muddy Waters 2025-03-03

FTAI Aviation, Ltd. FTAI

An FTAI Aviation Module Factory box appears in an Iranian MRO's LinkedIn posts, suggesting FTAI may have indirectly violated U.S. OFAC sanctions on Iran.

N3 V3 C3
Muddy Waters 2025-01-15

FTAI Aviation Ltd. FTAI

FTAI is a dressed-up engine-leasing business posing as a high-margin MRO — whole-engine sales counted as three modules and intra-segment depreciation transfers fabricate the aerospace-aftermarket story.

N5 V3 C3
Kerrisdale Capital 2025-01-09

Red Cat Holdings, Inc. RCAT

Red Cat's $1bn valuation rests on inflating a $23M/year Army drone contract into a $350M sole-source bonanza, with a factory that can't scale and insiders heading for the exits.

N4 V2 C2
Muddy Waters 2024-11-20

e.l.f. Beauty, Inc. ELF

ELF's imports collapsed while inventory and revenue kept soaring; reconciling the two suggests $138-188mm of overstated sales and a likely fraud.

N5 V3 C3
Kerrisdale Capital 2024-11-01

Oklo Inc. OKLO

Oklo is a $3bn pre-revenue SPAC nuclear story whose 5x-lowballed fuel costs, unrealistic 2027 NRC timeline, and inexperienced 'Nuclear Bros' management mean shares should collapse as reality intrudes.

N4 V3 C2
Citron Research 2024-09-24

Multiple (portfolio update)

AGL short worked: $5 PT set when stock was $25, fell to target on unprofitable model

N2 V2 C1
Kerrisdale Capital 2024-08-15

Lumen Technologies LUMN

Lumen's 400% AI-fueled rally is an optical illusion: $5bn in PCF deals is construction-contractor funding worth ~$1/share, masking an insolvent, secularly declining telco with $19bn debt.

N4 V3 C2
Starboard Value 2024-08-01

Autodesk, Inc. ADSK

Autodesk's premier software franchise is squandered under CEO Anagnost — peer-lagging margins, missed Investor Day targets and manipulated billings demand a Board-led overhaul to unlock 45% operating margins.

N4 V3 C3
Muddy Waters 2024-07-23

Eurofins Scientific SE ERF

Eurofins' €556m 'excess cash' earned just 1.42% vs banks' quoted ~2.88%, echoing the NMC Health fraud tell; only radical disclosure on cash, entities, and Dr. Martin's real estate can clear it.

N4 V2 C2
Muddy Waters 2024-07-03

Eurofins Scientific SE ERF

Eurofins' 800+ immaterial subsidiaries and 18 auditors enable sham sales and cash double-counting; new evidence, including a factoring denial contradicted by a former BU head, argues the financials cannot be trusted.

N4 V2 C2
Muddy Waters 2024-06-24

Eurofins Scientific SE ERF

Muddy Waters is short Eurofins: controlling shareholder Dr. Gilles Martin has siphoned capital via above-market real-estate leasebacks for 20 years, and the financials appear engineered to overstate revenue, profits, and cash.

N4 V2 C2
Muddy Waters 2024-06-03

CPI Property Group S.A. CPIPGR

CPI PG's controlling shareholder Vitek swapped €273m of personal debt for Dubai properties still under construction, sticking CPI PG with ~€220m of hidden progress payments while pocketing ~€118m.

N4 V2 C2
Kerrisdale Capital 2024-06-01

Riot Platforms, Inc. RIOT

Riot Platforms is a serial-diluting bitcoin miner with $140k+ all-in cost per coin, rising Texas regulatory risk, and a broken model increasingly obviated by low-fee BTC ETFs.

N4 V3 C2
Muddy Waters 2024-05-29

CPI Property Group S.A. CPIPGR

CPI Property Group's luxury London transactions — same-day flips, offshore proxies, and uneconomic sales to PEPs — bear hallmarks of money laundering integration using bondholder funds.

N4 V3 C3
Muddy Waters 2024-04-08

CPI Property Group CPIPG

CPIPG's 2023 results show undisclosed related-party transfers to controlling shareholder Vitek, aggressive fair-value inflation, and an unreconciled 92% equity collapse at GSG Berlin — management must answer on the call.

N4 V2 C2
Muddy Waters 2024-02-15

Fairfax Financial Holdings Ltd. FFH

Muddy Waters poses five forensic questions to Fairfax management that, if answered honestly, would expose return-of-capital dividends, off-balance-sheet debt via NCIs, and fair-value gain engineering.

N3 V1 C1
Muddy Waters 2024-02-08

Fairfax Financial Holdings Ltd. FFH

Muddy Waters is short Fairfax Financial, arguing it is 'the GE of Canada' — a serial accounting manipulator whose book value is overstated by ~$4.5bn (~18%) through value-destructive transactions.

N4 V3 C2
Muddy Waters 2024-01-25

CPI Property Group S.A. CPIPGR

CPI PG's Italian landbank and St. Tropez villa deals show ~€100M in unexplained cash and receivables gaps, suggesting controlling shareholder Vitek is using bondholder money to strip assets and launder cash.

N4 V3 C2
Muddy Waters 2024-01-22

CPI Property Group S.A. CPIPGR

Muddy Waters is short CPI Property Group's credit: its €19.2B portfolio appears inflated via implausible Berlin gains, cherry-picked Bubny landbank comps, and occupancy rates realtor listings show are overstated by ~2x.

N4 V3 C3
Muddy Waters 2023-12-06

Blackstone Mortgage Trust, Inc. BXMT

BXMT's borrowers only stay current because of expiring rate swaps; as ~$16B of swaps terminate in 2024, dividend cuts of 33-85% and $2.5-4.5B of loan losses could wipe out the $4B market cap.

N4 V2 C2
Muddy Waters 2023-11-30

CPI Property Group CPIPGR

Follow-up to Muddy Waters' Part 1 report: a list of pointed questions challenging CPI Property Group to explain self-dealing transactions through which controlling shareholder Radovan Vitek is allegedly asset-stripping the company.

N3 V1 C1
Muddy Waters 2023-11-21

CPI Property Group S.A. CPIPGR

Muddy Waters is short CPI PG's credit: controlling shareholder Radovan Vitek is brazenly looting the company via undisclosed related-party deals — ~50% of €1.2bn examined transactions appear suspect.

N4 V3 C3
Citron Research 2023-11-06

Apellis Pharmaceuticals APLS

Citron shorts Apellis, arguing its new Geographic Atrophy drug Syfovre faces an imminent FDA warning as AAO ophthalmologists reject it 83%-17% and vasculitis cases mount.

N4 V2 C2
Muddy Waters 2023-11-01

Sunrun RUN

Sunrun's Subscriber metric is fabricated — inflated ~20% above EIA filings — letting it overclaim ~$205M in IRS tax credits and prop up a fictitious valuation; Muddy Waters remains short.

N4 V2 C1
Muddy Waters 2023-10-25

Sunrun Inc. RUN

Sunrun's non-GAAP Subscriber count exceeds mandatory EIA filings by ~20%, implying phantom customers, ~$1.5B of overstated Net Earning Assets (62.5% of market cap), and possible ITC tax fraud.

N4 V2 C2
Muddy Waters 2023-08-04

Vivion Investments

Vivion's proposed bond exchange rests on inflated UK hotel valuations — illustrated by Crowne Plaza Heathrow, marked at EUR94.6m versus CBRE's EUR72.9m — serving insiders, not bondholders.

N4 V2 C3
Muddy Waters 2023-06-07

Chinook Therapeutics KDNY

Chinook manipulated 2021-2022 revenues via its Chinese JV SanReno; strip out the accounting tricks and reported revenue collapses by 95% and 68% respectively, reinforcing our short.

N4 V2 C1
Muddy Waters 2023-05-16

Chinook Therapeutics Inc KDNY

Muddy Waters is short Chinook (KDNY): lead drug atrasentan is inefficacious, harmful, and blocked by sparsentan's IgAN orphan-drug exclusivity — FDA approval is highly unlikely.

N4 V2 C2
Citron Research 2023-04-19

Freedom Holding Corp FRHC

FRHC funnels 85% of revenue through a CEO-owned Belize affiliate (FFIN) sourcing Russian flows — an FTX/Alameda structure that should trigger restatement, sanctions violations, and Nasdaq delisting.

N4 V2 C1
Muddy Waters 2023-03-28

Vivion Investments

Muddy Waters stays short Vivion bonds: the December 2022 rebuttal is misleading, asset values are inflated, rent24 exposure is hidden, and shareholder loans are being cashed out with bondholder money.

N3 V2 C2
Muddy Waters 2022-12-14

Vivion Investments S.à.r.l.

Vivion's €1.44bn bond issuer is a multi-billion euro shell game — fabricated shareholder loans, inflated occupancy and fair value gains, and related-party rents enriching controlling shareholder Amir Dayan.

N4 V2 C2
Muddy Waters 2022-12-01

dLocal DLO

DLO's refusal to reconcile 2020 cash flows in writing, while verbally denying misuse on broker calls, confirms Muddy Waters' view that client funds financed the pre-IPO special dividend.

N3 V1 C1
Muddy Waters 2022-11-16

DLocal Ltd. DLO

Muddy Waters is short DLO: contradictory TPV disclosures, implausibly high FX-driven take rates, governance failures and ~$1bn of insider selling point to likely fraud at the Uruguay-based payments processor.

N4 V2 C2
Kerrisdale Capital 2022-09-01

AST SpaceMobile, Inc. ASTS

AST SpaceMobile is a $1.8bn 2021-SPAC promoting a physically implausible direct-to-handset satellite broadband dream; the technology won't work as hyped, timelines keep slipping, and SpaceX/Apple competition eliminates any lead.

N4 V2 C2
Muddy Waters 2022-08-25

Hannon Armstrong Sustainable Infrastructure Capital HASI

HASI is 'dumb money' in renewables JVs — sponsors cash out while HASI books non-cash HLBV income on investments unlikely to ever pay out, inflating reported earnings over real economics.

N4 V2 C1
Muddy Waters 2022-08-03

Sunrun RUN

Muddy Waters rebuts Sunrun's response: the 90% PPA-renewal assumption on 20-year-old panels is fantasy, the $668M panel-removal liability is real, and RUN hides its tax basis.

N3 V1 C1
Muddy Waters 2022-07-28

Sunrun Inc. RUN

Sunrun's equity story rests on three shaky pillars — inflated subscriber values, abusive IRS tax-basis gaming, and fragile ABS — that together imply an 85% haircut to Net Earning Assets.

N4 V2 C2
Muddy Waters 2022-07-12

Hannon Armstrong Sustainable Infrastructure Capital HASI

HASI is a short: its GAAP and non-GAAP 'Distributable Earnings' are inflated by three non-cash accounting tricks and roundtripped SunStrong loans, masking a cash-losing, capital-raise-dependent business.

N4 V2 C1
Kerrisdale Capital 2022-04-01

Digital World Acquisition Corp DWAC

DWAC's $8bn pro-forma SPAC merger with Trump's TMTG will never close because the SEC is actively investigating it and can kill the deal via a stop order — fair value is the $10 trust cash (-80%).

N4 V2 C2
Muddy Waters 2021-12-16

KE Holdings BEKE

BEKE is systemic fraud: platform scraping and field work show new-home GTV inflated ~126%, revenues inflated 77-96%, with ghost stores, clone stores, and a sham acquisition masking the deception.

N5 V2 C2
Kerrisdale Capital 2021-12-01

Astra Space, Inc. ASTR

Astra is a SPAC-bubble rocket company with no revenue, an undersized non-reusable vehicle, and fantastical 300-launch-a-year forecasts; shares should tumble back to the ground.

N4 V3 C3
Muddy Waters 2021-09-15

Danimer Scientific DNMR

DNMR is a post-SPAC bioplastics story whose 'sold-out' demand, $200M take-or-pay contracts, and $1 trillion TAM are misrepresentations — actual utilization is ~28% and Novomer is a Hail Mary.

N4 V2 C1
Kerrisdale Capital 2021-07-01

Acutus Medical Inc. AFIB

N3 V3 C3
Muddy Waters 2021-05-24

Solutions 30 S30

EY's refusal to sign Solutions 30's 2020 audit — after S30 blocked access to information on suspect transactions — confirms Muddy Waters' two-year-old fraud and money-laundering thesis.

N4 V1 C1
Muddy Waters 2021-05-13

Lemonade, Inc. LMND

Muddy Waters is short Lemonade after discovering a critical session-fixation flaw that exposed customer PII to Google's index — a negligence that shatters Lemonade's 'trustworthy' digital-native brand.

N4 V1 C1
Muddy Waters 2021-03-10

XL Fleet XL

XL Fleet's March 8 rebuttal fails to deny Muddy Waters' core claims — exaggerated pipeline, ~10% reorder rate, overstated fuel savings — confirming XL is SPAC trash.

N3 V1 C1
Muddy Waters 2021-03-03

XL Fleet Corp XL

XL Fleet is SPAC trash: salespeople were paid to fabricate pipeline, most touted customers are inactive, ROI is actually negative, and the stock is worth a fraction of its billion-dollar SPAC valuation.

N5 V3 C3
Muddy Waters 2020-11-18

Joyy Inc. YY

JOYY is a multibillion-dollar fraud: ~90% of YY Live and ~80% of Bigo revenue is fabricated via bots and gift roundtripping, and Baidu's pending $3.6bn acquisition is buying air.

N5 V2 C2
Muddy Waters 2020-11-11

MultiPlan Corp MPLN

MultiPlan is a financially-engineered SPAC corpse losing its biggest customer UHC to UHC's own competitor Naviguard; expect 35% revenue loss and 8x+ leverage by 2022.

N4 V2 C2
Muddy Waters 2020-09-22

Nano-X Imaging Ltd. NNOX

Nanox's $1.3B medical-imaging story is a stock promotion: the ARC device appears to be a prop, distribution partnerships are shams, and a convicted felon engineered the IPO.

N5 V2 C1
Kerrisdale Capital 2020-09-01

AtriCure, Inc. ATRC

AtriCure's 7.5x revenue valuation assumes stand-alone Convergent succeeds, but electrophysiologists won't refer, and PFA plus real-time mapping will obsolete surgical ablation.

N4 V3 C2
Muddy Waters 2020-06-02

eHealth, Inc. EHTH

EHTH books Medicare Advantage revenue today that takes nine to twenty years to collect, masking a cash-incinerating, high-churn business reminiscent of Enron-style accounting.

N4 V2 C2